JACC. Cardiovascular imaging · 2026
Comprehensive Aortic Stenosis Characterization Using Multiview Deep Learning.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ieki Hirotaka, Sahashi Yuki, Vukadinovic Miloš, Rawlani Meenal, Binder Christina, Yuan Neal, Ambrosy Andrew P, Go Alan S, Chen Wansu, Lee Ming-Sum, He Bryan, Cheng Paul, Ouyang David
Аннотация
BACKGROUND: Accurate assessment of aortic stenosis (AS) requires integration of both structural and functional information characterized by visual traits as well as quantitation of gradients. Existing artificial intelligence models use solely either structural or functional information.
OBJECTIVES: The authors aimed to develop and validate an automated multiview deep learning framework to assess AS severity.
METHODS: The authors developed EchoNet-AS, an open-source end-to-end integrated approach combining video-based convolutional neural networks to assess valve motion with segmentation models to automate measurement of aortic valve peak velocity and classify AS severity.
RESULTS: EchoNet-AS was trained on 210,193 images from 16,076 studies from KPNC (Kaiser Permanente Northern California) and validated on 1,588 held-out test studies and a temporally distinct cohort of 19,202 studies. The final model was also externally validated on 2,415 studies from SHC (Stanford Healthcare) and 9,038 studies from CSMC (Cedars-Sinai Medical Center). Combining assessments from multiple echocardiographic videos and Doppler measurements, EchoNet-AS achieved excellent discrimination of severe AS with an area under the receiver-operating characteristic curve of 0.964 (95% CI: 0.952-0.973) in the KPNC held-out cohort and 0.986 (0.983-0.989) in the temporally distinct cohort, which was superior to models using single views or only Doppler measurements. The performance was consistently robust in distinct external cohorts with an area under the receiver-operating characteristic curve of 0.985 (0.975-0.992) at SHC and 0.989 (0.986-0.992) at CSMC.
CONCLUSIONS: EchoNet-AS synthesizes information from both B-mode videos and Doppler images to accurately assess AS severity. Its strong performance generalizes robustly to external validation cohorts and shows potential as an automated clinical decision support tool.
OBJECTIVES: The authors aimed to develop and validate an automated multiview deep learning framework to assess AS severity.
METHODS: The authors developed EchoNet-AS, an open-source end-to-end integrated approach combining video-based convolutional neural networks to assess valve motion with segmentation models to automate measurement of aortic valve peak velocity and classify AS severity.
RESULTS: EchoNet-AS was trained on 210,193 images from 16,076 studies from KPNC (Kaiser Permanente Northern California) and validated on 1,588 held-out test studies and a temporally distinct cohort of 19,202 studies. The final model was also externally validated on 2,415 studies from SHC (Stanford Healthcare) and 9,038 studies from CSMC (Cedars-Sinai Medical Center). Combining assessments from multiple echocardiographic videos and Doppler measurements, EchoNet-AS achieved excellent discrimination of severe AS with an area under the receiver-operating characteristic curve of 0.964 (95% CI: 0.952-0.973) in the KPNC held-out cohort and 0.986 (0.983-0.989) in the temporally distinct cohort, which was superior to models using single views or only Doppler measurements. The performance was consistently robust in distinct external cohorts with an area under the receiver-operating characteristic curve of 0.985 (0.975-0.992) at SHC and 0.989 (0.986-0.992) at CSMC.
CONCLUSIONS: EchoNet-AS synthesizes information from both B-mode videos and Doppler images to accurately assess AS severity. Its strong performance generalizes robustly to external validation cohorts and shows potential as an automated clinical decision support tool.